Literature DB >> 28624663

Role of exercise electrocardiogram to screen for T-wave oversensing after implantation of subcutaneous implantable cardioverter-defibrillator.

Muhammad R Afzal1, Christopher Evenson2, Auroa Badin1, Dilesh Patel1, Hemant Godara1, Michael Essandoh3, Toshimasa Okabe1, Jaret Tyler1, Mahmoud Houmsse1, Ralph Augostini1, John Hummel1, Steven Kalbfleisch1, Emile G Daoud1, Raul Weiss4.   

Abstract

BACKGROUND: During early experience with subcutaneous implantable cardioverter-defibrillators (S-ICD), several patients had inappropriate shocks from T-wave oversensing (TWOS) during exercise. This prompted some operators to perform routine treadmill exercise tests after implantation of S-ICD to screen for TWOS. Meanwhile, improvements have been made in the detection algorithms by the manufacturer.
OBJECTIVE: To assess whether routine treadmill exercise post S-ICD implantation is warranted.
METHODS: Patients undergoing S-ICD implantation from October 2012 to December 2016 who were able to complete a treadmill exercise were included in the study. The amplitude of R and T waves as assessed by the device programmer at rest and peak exercise was calculated and incidence of TWOS recorded.
RESULTS: Eighty-seven patients with complete treadmill exercise test data were included in the final analysis. The majority of the patients received S-ICD for primary prevention. Nine percent of the included patients had hypertrophic obstructive cardiomyopathy. During treadmill exercise, there was significant increase in the heart rate from rest (77 ± 14 beats per minute) to peak exercise (133 ± 14 beats per minute; P < .0001). There was no significant difference between R-wave amplitude at rest (2 ± 0.77 mV) and peak exercise (1.88 ± 0.94 mV; P = .36). Similarly, there was no significant difference between T-wave amplitude at rest (0.27 ± 0.19 mV) and peak exercise (0.33 ± 0.23 mV; P = .06). The incidence of TWOS during exercise was zero.
CONCLUSIONS: With current screening and detection algorithms for S-ICD, routine treadmill exercise does not result in additional discrimination of patients susceptible to TWOS.
Copyright © 2017 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Defibrillator; Exercise electrogram; Subcutaneous defibrillator; Sudden cardiac death; T-wave oversensing

Mesh:

Year:  2017        PMID: 28624663     DOI: 10.1016/j.hrthm.2017.06.022

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  8 in total

Review 1.  [Management of inappropriate shocks/T-wave-oversensing in S-ICD®-patients].

Authors:  Robert Larbig; Markus Bettin; Lukas J Motloch; Alicia Fischer; Niklas Bode; Gerrit Frommeyer; Florian Reinke; Andreas Loeher; Lars Eckardt; Julia Köbe
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2018-02-12

2.  Appropriate and inappropriate shocks in hypertrophic cardiomyopathy patients with subcutaneous implantable cardioverter-defibrillators: An international multicenter study.

Authors:  Babak Nazer; Zack Dale; Gianmarco Carrassa; Nosheen Reza; Tuna Ustunkaya; Nikolaos Papoutsidakis; Andrew Gray; Stacey J Howell; Miriam R Elman; Paolo Pieragnoli; Giuseppe Ricciardi; Daniel Jacoby; David S Frankel; Anjali Owens; Iacopo Olivotto; Stephen B Heitner
Journal:  Heart Rhythm       Date:  2020-02-18       Impact factor: 6.343

Review 3.  Safety, Efficacy and Evidence Base for Use of the Subcutaneous Implantable Cardioverter Defibrillator.

Authors:  Carmen Adduci; Francesca Palano; Pietro Francia
Journal:  J Clin Med       Date:  2018-03-11       Impact factor: 4.241

4.  A case of pseudo-appropriate shock.

Authors:  Neal J Ferrick; John D Fisher; Jay N Gross; Andrew K Krumerman
Journal:  HeartRhythm Case Rep       Date:  2020-03-13

Review 5.  The subcutaneous implantable cardioverter defibrillator--review of the recent data.

Authors:  Stacy B Westerman; Mikhael El-Chami
Journal:  J Geriatr Cardiol       Date:  2018-03       Impact factor: 3.327

6.  Inappropriate shock from delayed T-wave oversensing by a subcutaneous implantable cardioverter-defibrillator after septal myectomy for hypertrophic cardiomyopathy.

Authors:  Benjamin C Salgado; Rita Coram; John Mandrola; Rakesh Gopinathannair
Journal:  HeartRhythm Case Rep       Date:  2018-06-15

7.  SMART pass will prevent inappropriate operation of S-ICD.

Authors:  Motomi Tachibana; Nobuhiro Nishii; Kimikazu Banba; Shinpei Fujita; Etsuko Ikeda; Keisuke Okawa; Hiroshi Morita; Hiroshi Ito
Journal:  J Arrhythm       Date:  2018-11-20

8.  Approaches to Minimizing Periprocedural Complications During Subcutaneous Implantable Cardioverter-defibrillator Placement.

Authors:  Srikanth Vedachalam; Schuyler Cook; Tanner Koppert; Toshimasa Okabe; Raul Weiss; Muhammad R Afzal
Journal:  J Innov Card Rhythm Manag       Date:  2020-05-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.